.@ElligoHealth has acquired ePatientFinder’s technology and our practice network and is streamlining patient identification and feasibility: https://t.co/rXV1nYQgnr
.@athenahealth, which has partnerships to support #clinicaltrials recruitment (such as with @epatientfinder), has received an unsolicited acquisition offer from Elliott Management https://t.co/waKVR53atd
Clinical trials are by their very nature experimental since they relate to products/uses that are not yet approved and may entail risk. The potential risks and reasonably expected benefits of any trial will be explained to the patient before they agree to participate.
A4: Communication is key between healthcare providers and patients, but 60% of #HCPs did not recommend a single patient for a clinical study in the last year, according to a SERMO survey. What are the barriers? #ctaw2018
#DYK Clinical Trials Awareness Week kicked-off yesterday? Learn more about the event and how it’s helping us get #OnePersonCloser to new medicine right now! https://t.co/8MX00mdYzb #CTAW2018#ClinicalTrialsMatter
Doctors: Sharing information about #clinicaltrials is critical to help move new medicines forward. One more person reached is one step closer to new therapies. Get #OnePersonCloser today: https://t.co/BG6omZlZt6
According to a @SCORRmarketing study, there’s more we can do to engage patients in clinical research. Read how we can get #onepersoncloser to improving participation at all stages of a #clinicaltrial: https://t.co/vAtCBQZdET
Clinical trials allow us to make breakthrough discoveries. Read how one clinical trial has allowed researchers to zero-in on a specific protein: https://t.co/J5LIbyuri5 #OnePersonCloser#ClinicalTrials
Ken Getz just reported at #CTCollaborations that the capitalized costs of developing a single successful drug is approaching $3 billion and eligibility criteria has risen by 60% and endpoints by 50%.
#Patient participation in #clinicaltrials is needed to make advancements in medical treatments. Be that 1 in 6 to help bring us #OnePersonCloser to developing lifesaving treatments: https://t.co/mR18qthDgy